Inovio Pharmaceuticals Inc. closed 84.02% below its 52-week high of $12.33, which the company reached on July 26th.

Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday's session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses. Inovio ...

The stock's fall snapped a four-day winning streak.